ANI Pharmaceuticals Inc. (ANIP)

ANIP trades at $89.7, 12.1% above the near-term max pain of $80 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($75-$110), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ANIP shows a downward trend from 110 to 75, indicating bearish sentiment or hedging activity. The 39% spread signals divergent expectations across timeframes. Levels distributed around 89.7. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.